Concepedia

Steve Pascoe

SP

Statistics

Publications

9

Citations

973

H-Index

9

Active since

2007

Affiliations

Novartis (Switzerland)(Current)

Novartis (United Kingdom)

University College London

St George's, University of London

University of Pennsylvania

Steve Pascoe is an author at Novartis (Switzerland) specializing in pharmacotherapy, pharmacology, and chronic obstructive pulmonary disease.

Publications per year

2007–2020

9

Publications

9

Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy

Hossein Ardeschir Ghofrani, Nicholas W. Morrell, Marius M. Hoeper et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 383 citations · Full text

, , +14

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

Ian Pavord, Sally Lettis, Nicholas Locantore et al. · Thorax · 2015 · 326 citations · Full text

, , +17

Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis

Paul Jones, James F. Donohue, Jerry Nedelman et al. · Respiratory Research · 2011 · 81 citations · Full text

, , +17

The effect of exacerbation history on outcomes in the IMPACT trial

David Halpin, Mark T. Dransfield, MeiLan K. Han et al. · European Respiratory Journal · 2020 · 39 citations · Full text

, , +17

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects

Salim Abdulla, Mbaraka Amuri, Abdunoor M. Kabanywanyi et al. · Malaria Journal · 2010 · 34 citations · Full text

, , +16

1–5 of 9